FDA Approves Lynkuet (elinzanetant) for Moderate to Severe Hot Flashes Due to Menopause

Oct 26, 2025 - 03:00
 0  0
WHIPPANY, N.J., October 24, 2025 – Bayer announced today the U.S. Food and Drug Administration (FDA) has approved Lynkuet® (elinzanetant) 60mg capsules, the first and only dual neurokinin (NK) targeted therapy,1 neurokinin 1 (NK1) and...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0